Platelet Disorders Flashcards
Most common cause of bleeding
Thrombocytopenia
T/F: pts with thrombocytosis are usually asymptomatic
True
Pts with _____ _____ (a myeloproliferative d/o) may have bleeding, thrombosis, or both as a component of their presentation
Essential thrombocythemia
Complication due to vasomotor changes that occurs with essential thrombocythemia characterized by burning pain and responds to aspirin therapy
Erythromelalgia
4 drugs/drug classes that are known for lowering the platelet count
Loop diuretics
H2 blockers
Digoxin
Abx
process involved in pseudothrombocytopenia and the characteristic finding on peripheral smear
Pseudothrombocytopenia is an in vitro sampling error resulting from CBC drawn in EDTA tube
Characteristic finding is in vitro clumping
What is the plan for additional evaluation of a measured platelet count in pseudothrombocytopenia?
Repeat CBC in heparin or citrate tube
4 disorders that affect platelet production
B12 or folate deficiency — associated with pancytopenia, macrocytosis, macro-ovalocytes, hypersegmented neutrophils, and possible neuro sxs
Bone marrow disorder (acute leukemia, aplastic anemia, myelodysplastic syndrome)
Toxin or drug-mediated bone marrow injury
Infection (HIV, Hep B and C, EBV, rubella, DIC, other infections)
Describe workup for pt with thrombocytopenia in which platelet count is <100,000/microliter
Exclude pseudothrombocytopenia on PB smear
Abnormal blood smear or abnormality of WBC or RBC suggests bone marrow d/o
Large spleen suggests hypersplenism
Immune mediated; primary or secondary ITP; drug-induced
Describe workup for pt with thrombocytopenia in which platelet count is >100,000/microliter
Exclude pseudothrombocytopenia on PB smear
Follow CBC — if stable, just continue to observe
Management for thrombocytopenia in aplastic anemia
Tx aplastic anemia w/ allogeneic HCT in pts <40 that are otherwise healthy with HLA-compatible sibling
Pts not eligible for above can get immunosuppressives with antithymocyte globulin and cyclosporin
Tx for thrombocytopenia due to marrow invasion
Treat if symptomatic
Supportive care = red cell and/or platelet transfusion
Low intensity therapy = hematopoietic growth factors, immunosuppressives, lenalidomide
High intensity therapy = chemo with allogeneic HCT
How does hypersplenism lead to platelet sequestration
Cytopenias result from increased destruction of cell elements secondary to reduced flow of blood through enlarged and congested cords or to immune-mediated mechanisms
How does ITP result in platelet destruction?
Autoantibodies — arise in 3 settings — response to a drug (quinine), association with a disease (HIV, SLE, H.pylori, etc), or idiopathic
Consumptive thrombocytopenia and microangiopathic hemolysis from platelet thrombi that form throughout microvasculature
Presents with fever, AKI, and fluctuating neuro signs
TTP-HUS
Lab findings in TTP-HUS
Prominent schistocytes, decreased haptoglobin, elevated LDH, check for ADAMSTS13
Management of ITP
Glucocorticoids +IVIG
[consider immunosuppressives — anti-Rho Ig, rituximab]
HIT management
Discontinue heparin, replace with rapidly acting AC (lepirudin, argabotran)
TTP/HUS management
Plasma exchange transfusion and glucocorticoids; can consider rituximab
[in young pts with HUS d/t O157H7 just do supportive care — better px]
Disorders that result in secondary thrombocytosis
Acute blood loss Iron deficiency Asplenic states Recovery from thrombocytopenia Malignancy Chronic inflamm/infectious dz Acute inflamm/infectious dz Response to exercise Response to drugs (vincristine, epinephrine, ATRA, cytokines, growth factors)
Meds that affect platelet function
ASA NSAIDs Dipyradimole Clopidogrel Ticlopidine Ticagrelor Abciximab Eptifibitide Nitrates Ca channel blockers Heparin
List inherited d/o of platelet function
Bernard Soulier Gray platelet syndrome VW disease Wiskott aldrich Chediak hegashi Hermansky pudlak Glanzmann thrombasthenia
Defect in gray platelet syndrome
Defect is in platelet alpha granules
Defect in glanzmann thrombasthenia
Defect is in GPIIB/IIIA